ROI Financial Advisors’s Idexx Laboratories IDXX Stock Holding History

ROI Financial Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$549K	Buy	1,042 +72	+7%	+$40.4K	0.28%	48
2026 Q1	$545K	Buy	970 +33	+4%	+$21.2K	0.33%	48
2025 Q4	$634K	Sell	937 -30	-3%	-$20.4K	0.36%	39
2025 Q3	$618K	Sell	967 -595	-38%	-$361K	0.37%	40
2025 Q2	$838K	Sell	1,562 -709	-31%	-$339K	0.53%	34
2025 Q1	$954K	Sell	2,271 -1,051	-32%	-$456K	0.69%	32
2024 Q4	$1.37M	Sell	3,322 -675	-17%	-$296K	0.94%	27
2024 Q3	$2.02M	Buy	3,997 +64	+2%	+$31.1K	1.39%	19
2024 Q2	$1.91M	Sell	3,933 -6	-0.2%	-$3.01K	1.39%	19
2024 Q1	$2.13M	Sell	3,939 -25	-0.6%	-$13.7K	1.67%	18
2023 Q4	$2.2M	Buy	+3,964	New	+$1.86M	1.82%	18

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

ROI Financial Advisors's IDXX Position: Q2 2026 in Review

ROI Financial Advisors increased its Idexx Laboratories (IDXX) stake by 7.4% in Q2 2026, buying an estimated $40.4K and bringing the position to 1,042 shares worth $549K. The position accounts for 0.28% of the portfolio, ranked #48.

ROI Financial Advisors first reported a position in IDXX in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.2M in Q4 2023. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

ROI Financial Advisors held 1,042 shares of Idexx Laboratories worth $549K as of Q2 2026.
ROI Financial Advisors bought 72 Idexx Laboratories shares in Q2 2026, an estimated $40.4K.
Idexx Laboratories made up 0.28% of ROI Financial Advisors's portfolio in Q2 2026, its #48 holding.
ROI Financial Advisors first reported a position in Idexx Laboratories in Q4 2023 and has held it in 11 quarters since.
ROI Financial Advisors's Idexx Laboratories position peaked at $2.2M in Q4 2023.
1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on ROI Financial Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.